Videos

BrainScope | Susan Hertzberg, CEO

FDA cleared non-invasive medical device that objectively assesses head injured patients for both brain bleeds & concussions at point of care.

Sense Neuro Diagnostics | Geoffrey Klass, CEO

Sense is developing a non-invasive, wearable device that continuously monitors brain activity primarily in the intensive care unit.

Moterum Technologies | David Huizenga, CEO

High impact products in the field of mobility and rehabilitation for those who have survived a stroke, traumatic brain injury, or spinal injury.

IRegained | Vineet Johnson, CEO

IRegained's MyHand system is a neuro-rehabilitation device to restore motor control to the hand in patients who have sustained brain injury due to stroke, accident, or TBI.

NextSense | Jonathan Berent, CEO & Founder

NextSense is a developer of a real-world monitoring solution to obtain insights into brain health. The company's platform collects longitudinal electroencephalogram (EEG) data from biosensing earbuds that can be worn throughout the day and night.

Rhaeos | Anna Lisa Somera, CEO

Noninvasive thermal sensor for use in the monitoring of ventricular shunt function.

Braingrade | Peter Schlecht, CEO

Braingrade is developing a neurostimulation solution for patients with Alzheimer's disease that is intended to help them live longer, more independent lives.

SpinTech MRI | Karen Holzberger, President & CEO

The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency. The solution integrates with virtually all MRI systems and manufacturers.

MagForce USA | Ben Lipps, CEO

Nanotechnology-based therapy for the treatment of cancer.

Carevature | Dennis Farrell, President & CEO

Carevature Medical develops advanced orthopedic solutions to address limitations of current surgical solutions.

Leonhardt Ventures | Howard Leonhardt, CEO

The company is focused on organ regeneration & recovery innovations based on the convergence of bioelectrics & biologics.

Altoida | Travis Bond, CEO

Altoida is using technology to predict the onset of neurlogical diseases, such as Alzheimer's disease, before symptoms occur.

AiM Medical Robotics | Bob Cathcart, President & CEO

AiM Medical Robotics is developing a portable MRI compatible surgical robot for use in the OP and MRI suite. The system is being designed for the treatment of functional brain disorders (e.g. epilepsy, Parkinson's disease).

Nervonik | Barry Keenan, CEO

Developing a miniaturized neuromodulation device for therapeutic applications.